Satellos Bioscience MSLE
NASDAQ MSLE
$8.60 -0.21 (-2.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Receivables - Net (2024 - 2026)

Updated

Satellos Bioscience's Receivables - Net came in at $783,000 for the quarter ended Jun 30, 2026, up 7.9% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Receivables - Net (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Satellos Bioscience's Receivables - Net was $370,000, down 14.9% from the prior year.

  • Going back by year, Receivables - Net was $435,000 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Satellos Bioscience 136.19 Mn 136.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 783,000.00
Mar 31, 2026 726,000.00
Dec 31, 2025 370,000.00
Dec 31, 2024 448,121.56
API Access

Satellos Bioscience Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=MSLE&period=max&api_key=YOUR_API_KEY